May 7 (Reuters) - Phibro Animal Health Corp PAHC.O :
* QTRLY NET SALES OF $211 MILLION, AN INCREASE OF $5
MILLION, OR
2%
* QTRLY DILUTED EPS OF $0.33
* QTRLY ADJUSTED DILUTED EPS OF $0.38
* FOR MARCH QUARTER, OUR ANIMAL HEALTH SALES GREW AT A
HEALTHY 8%
RATE
* PHIBRO ANIMAL HEALTH - FOR JUNE QUARTER, SEEING
UNPRECEDENTED
DEMAND DISRUPTION AND PRODUCTION IMPACTS IN GLOBAL FOOD ANIMAL
INDUSTRY, DUE TO COVID-19
* PHIBRO ANIMAL HEALTH - ANTICIPATE DECLINE IN DEMAND FOR
PRODUCTS
IN JUNE QUARTER, AS OUR CUSTOMERS ATTEMPT TO NAVIGATE RAPIDLY
EVOLVING MARKET CONDITIONS
* WITHDRAWAL OF GUIDANCE FOR OUR FISCAL YEAR 2020
* BELIEVE CURRENT DIFFICULT SITUATION WILL BEGIN TO
NORMALIZE IN
SECOND HALF OF CALENDAR 2020
* Q3 EARNINGS PER SHARE VIEW $0.34, REVENUE VIEW $208.3
MILLION --
REFINITIV IBES DATA
* BELIEVE WE EXPERIENCED ONLY A MODEST BENEFIT FROM CUSTOMER
STOCKING IN QUARTER
Source text for Eikon: ID:nBw2Qb1Xba
Further company coverage: PAHC.O
((Briefs@thomsonreuters.com;))